Citations |
1.Bass, S. E., Sienkiewicz, P., Macdonald, C. J., Cheng, R. Y., Sparatore, A., Del Soldato, P., Roberts, D. D., Moody, T. W., Wink, D. A., and Yeh, G. C. Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. Clin Cancer Res, 15: 1964-1972, 2009. 2.Fukumori, S., Masago, M., Ishida, K., Kayano, Y., Taguchi, M., and Hashimoto, Y. Temperature-dependent specific transport of levofloxacin in human intestinal epithelial LS180 cells. Biopharm Drug Dispos, 30: 448-456, 2009. 3.Graber-Maier, A., Buter, K. B., Aeschlimann, J., Bittel, C., Kreuter, M., Drewe, J., and Gutmann, H. Effects of Curcuma extracts and curcuminoids on expression of P-glycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180. Planta Med, 76: 1866-1870. 4.Ishida, K., Takaai, M., Yotsutani, A., Taguchi, M., and Hashimoto, Y. Membrane transport mechanisms of mizoribine in the rat intestine and human epithelial LS180 cells. Biol Pharm Bull, 32: 741-745, 2009. 5.Takaai, M., Morishita, H., Ishida, K., Taguchi, M., and Hashimoto, Y. Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells. Eur J Pharmacol, 601: 61-65, 2008. 6.Yamasaki, D., Nakamura, T., Okamura, N., Kokudai, M., Inui, N., Takeuchi, K., Watanabe, H., Hirai, M., Okumura, K., and Sakaeda, T. Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. Eur J Pharm Sci, 37: 126-132, 2009. |
Description |
Disease: Colorectal adenocarcinoma Origin: Derived from a 58 year old female Caucasian with Dukes type B adenocarcinoma of the colon Species:Homo sapiens Tissue:Colon Morphology:Epithelial Properties:Adherent Cytogenic data:Tumorigenic, Modal no. 45 (2n=46) Patient:Female, Caucasian, 58 yrs of age Medium:AddexBio-formulated EMEM (C0005-01) + 10% FBS Subculture:1:2 to 1:4 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: HLA A2, B13, B50, IL6, IL10, mucin Isoenzymes: ADA, 1; ES-D, 1; G6PD, B; PEP-D, 1; PGD, A; PGM1, 1; PGM3, 2 DNA Profile (STR): Amelogenin: X ; CSF1PO: 10, 13; D13S317: 10; D16S539: 11, 13; D5S818: 10, 15; D7S820: 11, 9.3; THO1: 6, 7; TPOX: 8, 9; vWA: 15, 18 Mutations in LS-180 Cells Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: LS-180 (AddexBio C0009006) Related cells by Organ: Caco-2 cells CMT-93 cells COLO 205 cells DLD-1 cells HCA-7 cells HCT-116 cells HCT-8 cells HCT-15 cells HT-29 cells LoVo cells LS-180 cells LS-174T cells RKO cells SNU-407 cells SNU-503 cells SW1116 cells SW48 cells SW480 cells SW620 cells T84 cells |